Skip to main navigation Skip to search Skip to main content

A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of AUBAGIO Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients

Project: Research

Project Details

StatusFinished
Effective start/end date05/13/1405/1/16

Funding

  • Sanofi US Services Incorporated: $6,375.00